Visby Medical raises up to $65M to commercialize home STI test
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.

Jun 20, 2025 0
Jun 20, 2025 0
Jun 20, 2025 0
Jun 20, 2025 0
Jun 20, 2025 0
Or register with email
Apr 26, 2025 0
Jun 2, 2025 0
May 12, 2025 0
Jun 6, 2025 0
Jun 9, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.